Intrinsiqs

Is Indaptus Therapeutics, Inc. overvalued?

Indaptus Therapeutics, Inc. (INDP) — key valuation metrics and fundamentals.

No verdict
Price
$3.55
Fair value
Current P/E
Normal P/E
Market cap
$402.0M
Dividend yield
0.0%
Return on equity
-302.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares INDP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 16 Sep 2026.